StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3079% above fair value
$54.43−2.20 (-3.88%)

Close on Nov 20, 2026Market cap $4.87BP/E 39.2Yield –

Liquidia gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Liquidia's gross profit for the twelve months ending Mar 31, 2025 was $8.22M, down 33.0% year over year. For fiscal 2024 it was $8.12M, down 44.4% from the year before. The highest annual figure on record is $14.60M in fiscal 2023.

Annual gross profit

PeriodPeriod endValueChange
FY2024Dec 31, 2024$8.12M-44.4%
FY2023Dec 31, 2023$14.60M+11.7%
FY2022Dec 31, 2022$13.08M+33.0%
FY2021Dec 31, 2021$9.83M+1858.5%
FY2020Dec 31, 2020$501.92K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025$1.60M+6.5%
Q4 FY2024Dec 31, 2024$1.56M-55.8%
Q3 FY2024Sep 30, 2024$2.88M-7.2%
Q2 FY2024Jun 30, 2024$2.17M-47.4%
Q1 FY2024Mar 31, 2024$1.51M-60.8%
Q4 FY2023Dec 31, 2023$3.54M-24.2%
Q3 FY2023Sep 30, 2023$3.11M+28.2%
Q2 FY2023Jun 30, 2023$4.12M+29.1%
Q1 FY2023Mar 31, 2023$3.84M+37.2%
Q4 FY2022Dec 31, 2022$4.67M+87.5%
Q3 FY2022Sep 30, 2022$2.43M+5.9%
Q2 FY2022Jun 30, 2022$3.19M+19.7%
Q1 FY2022Mar 31, 2022$2.80M+17.1%
Q4 FY2021Dec 31, 2021$2.49M+395.9%
Q3 FY2021Sep 30, 2021$2.29M–
Q2 FY2021Jun 30, 2021$2.66M–
Q1 FY2021Mar 31, 2021$2.39M–
Q4 FY2020Dec 31, 2020$501.92K–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–

More Liquidia figures

See a number that looks wrong?